日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Hierarchical Zeolitic Imidazolate Framework-8@Au Cluster Nanocarriers for In Situ Chimeric Antigen Receptor Macrophage Programming and Immunotherapy in Prostate Cancer

用于前列腺癌原位嵌合抗原受体巨噬细胞编程和免疫治疗的分级沸石咪唑酯骨架-8@Au簇纳米载体

Liang, Zichen; Wang, Rui; Wang, Yiyang; Wang, Qing; Chen, Yihan; Zhang, Zehui; He, Mengyuan; Yang, Jiajie; Sun, Luchen; Zhang, Qing; Guo, Hongqian; Shen, Pingping; Yang, Nanfei

Analysis of the transcriptomic and metabolomic landscape of prostate cancer with different anatomical origins using snFLARE-seq and mxFRIZNGRND

利用snFLARE-seq和mxFRIZNGRND分析不同解剖起源的前列腺癌的转录组和代谢组图谱

He, Dongyin; Hu, Haoran; Xiao, Kai; Zhang, Yuhang; Cheng, Yongbing; Jiao, Shaozhuo; Hao, Yimei; Cai, Yuanyuan; Liu, Ziqun; Yan, Xinran; Chen, Qinsheng; Mu, Xiyan; Wang, Qi; Peng, Shan; Sang, Guoqin; Zhi, Xiaoling; Chang, Yanxia; Ye, Qing; Yang, Yuyao; Che, Meixia; Huang, Shengsong; Guo, Hongqian; Chen, Luonan; Tang, Huiru; Qiu, Xuefeng; Li, Zhenfei

Midkine-Mediated Microglia Activation after Renal Injury Promotes Cognitive Impairment Following Ischemic Renal Injury

肾损伤后中肾素介导的小胶质细胞活化促进缺血性肾损伤后的认知障碍

Lu, Li; Liu, Bixiao; Yang, Yu; Meng, Tao; Chang, Yuanyuan; Peng, Yao; Guo, Jia; Wang, Zhuqing; Guo, Hongqian; Zhou, Liuhua; Zhao, Xiaozhi

Tislelizumab Combined With Axitinib in Neoadjuvant Treatment of Locally Advanced Clear Cell Renal Cell Carcinoma: A Single-Center, Phase II Clinical Study

替雷利珠单抗联合阿昔替尼新辅助治疗局部晚期透明细胞肾细胞癌:一项单中心II期临床研究

Yang, Wenjin; Zhang, Shun; Liu, Guangxiang; Li, Hao; Wang, Xin; Jiang, Bo; Zhang, Gutian; Guo, Hongqian; Ji, Changwei

GSTA1 deficiency drives neuroendocrine differentiation via TNFRSF13B/c-FOS/CHGA axis in prostate cancer

GSTA1 缺陷通过 TNFRSF13B/c-FOS/CHGA 轴驱动前列腺癌的神经内分泌分化

Qian, Jiajun; Luo, Yang; Fu, Yao; Diao, Wenli; Ding, Qiubo; Chen, Wei; Qiu, Xuefeng; Guo, Hongqian

Clonotype-Resolved Single-Cell Multi-Omics Unlocks the Profile of Tumor-Infiltrating CD39⁺CD8⁺ T Cells and Enables Adoptive Cell Therapy for Solid Tumor.

克隆型解析的单细胞多组学揭示了肿瘤浸润 CD39âºCD8⺠T 细胞的特征,并为实体瘤的过继细胞疗法提供了可能。

Zhao Zihan, Wu Xiangyu, Jin Qingyang, Yang Xin, Zhu Wenjie, Jiang Ning, Liu Tianyao, Li Tianhang, Fang Feng, Guo Hongqian, Yang Rong

Preclinical activity of SHR-A1921, a novel antibody-drug conjugate targeting trophoblast cell-surface antigen2 (Trop-2) in prostate cancer

SHR-A1921是一种新型抗体药物偶联物,靶向滋养层细胞表面抗原2 (Trop-2),在前列腺癌中的临床前活性

Wang, Binyu; Xu, Qiuya; Peng, Shan; Han, Zheng; Huang, Haifeng; Guo, Hongqian; Qiu, Xuefeng

Toripalimab in patients with previously treated advanced upper tract urothelial carcinoma: a subgroup analysis of the phase II POLARIS-03 trial

托瑞普利单抗治疗既往接受过治疗的晚期上尿路尿路上皮癌患者:POLARIS-03 II期试验的亚组分析

Wei, Jinchang; Zhang, Ruiyun; Li, Juan; Li, Siming; Yan, Xieqiao; Chen, Haige; Guo, Hongqian; Hu, Bin; Liu, Ziling; Guo, Jun; Sheng, Xinan

SNW1 promotes lymphatic metastasis in bladder cancer by modulating SRPK1 splicing

SNW1通过调节SRPK1剪接促进膀胱癌淋巴转移

Hu, Jijie; Zhu, Ying; Wang, Guoli; Dai, Huiqi; Han, Haoyuan; Cao, Wenmin; Ding, Meng; Diao, Wenli; Lu, Qun; Zhang, Qing; Guo, Hongqian; Chen, Wei

bp-VI-RADS combined with normalized apparent diffusion coefficient enhances diagnostic efficacy for muscle-invasive bladder cancer

bp-VI-RADS 结合标准化表观扩散系数可提高肌层浸润性膀胱癌的诊断效能。

Hao, Zihan; Zhu, Li; Ding, Jiayang; Jin, Qingyang; Du, Xiang; Wang, Xiangyu; Shi, Yonghao; Guo, Hongqian; Li, Danyan; Yang, Rong